Literature DB >> 32830383

Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial.

Michael D Stein1,2, Kristina T Phillips3, Debra S Herman1,4, Julia Keosaian2, Catherine Stewart2, Bradley J Anderson1, Zoe Weinstein5, Jane Liebschutz6.   

Abstract

AIMS: To test the hypothesis that among hospitalized people who inject drugs (PWID), a brief intervention in skin-cleaning would result in greater reductions in follow-up emergency department (ED) or hospitalization rates compared with a usual care condition.
DESIGN: Randomized, two-group (intervention, n = 128; usual care, n = 124), single-site clinical trial with12-month follow-up.
SETTING: Hospital inpatient services in Boston, Massachusetts, United States. PARTICIPANTS: People who injected drugs on at least 3 days each week prior to hospital admission (n = 252). Participants averaged 37.9 (± 10.7) years of age; 58.5% were male, 59.3% were white and 61.1% had a diagnosis related to skin infection at enrollment. INTERVENTION AND COMPARATOR: Intervention was a skin hygiene education and skills-training behavioral intervention [short-term efficacy data on a behavioral intervention (SKIN)] consisting of two education- and skills-based skin-cleaning sessions, one during hospitalization and another 4 weeks later. The comparator was treatment as usual: an informational brochure about substance use treatment options and needle exchange programs in the area and follow-up clinical appointments as arranged by the inpatient medical staff. MEASUREMENTS: Electronic medical records were reviewed and discharge diagnoses for each ED visit and hospital admission were categorized into injection-related bacterial events (e.g. cellulitis) and non-injection-related events. Negative binomial regression was used to test the intervention effects for the primary outcome and total ED visits, as well as the secondary outcomes, total number of hospitalizations, injection drug use-related (IDU-related) ED visits and IDU-related hospitalizations. We also tested whether the outcomes were moderated by whether the initial hospitalization was IDU-related.
FINDINGS: Of people assigned to SKIN, 66 completed two sessions, 55 completed one session and seven completed zero sessions. Adjusting for baseline covariates, the mean rate of total ED visits in the next 12 months was non-significantly higher [incidence rate ratio (IRR) = 1.13, 95% confidence interval (CI) = 0.96, 1.33, P = 0.152] compared with usual treatment. The intervention did not significantly reduce total hospitalizations or IDU-related hospitalizations. Adjusting for baseline covariates, the mean rate of injection drug use-related ED visits in the next 12 months was lower (IRR = 0.57, 95% CI = 0.35, 0.91, P = 0.019) compared with treatment as usual.
CONCLUSIONS: A skin-cleaning intervention for people who inject drugs delivered during a hospitalization did not significantly reduce either overall emergency department use or hospitalization. There was some evidence that it may have reduced injection drug use-related emergency department visits. © 2020 Society for the Study of Addiction.

Entities:  

Keywords:  Health service utilization; opioid; people who inject drugs (PWID); skin and soft tissues infections (SSTI); skin-cleaning; substance use

Mesh:

Substances:

Year:  2020        PMID: 32830383     DOI: 10.1111/add.15236

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  8 in total

1.  Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.

Authors:  Thomas D Brothers; Dan Lewer; Nicola Jones; Samantha Colledge-Frisby; Michael Farrell; Matthew Hickman; Duncan Webster; Andrew Hayward; Louisa Degenhardt
Journal:  PLoS Med       Date:  2022-07-19       Impact factor: 11.613

2.  Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids.

Authors:  Raagini Jawa; Michael D Stein; Bradley Anderson; Jane M Liebschutz; Catherine Stewart; Kristina T Phillips; Joshua A Barocas
Journal:  AIDS Behav       Date:  2021-09-12

3.  Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs.

Authors:  Christina E Freibott; Kristina T Phillips; Bradley J Anderson; Catherine Stewart; Jane M Liebschutz; Michael D Stein
Journal:  J Addict Med       Date:  2022 Mar-Apr 01       Impact factor: 3.702

4.  Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.

Authors:  Raagini Jawa; Michael D Stein; Bradley Anderson; Jane M Liebschutz; Catherine Stewart; Kristina T Phillips; Joshua A Barocas
Journal:  Int J Drug Policy       Date:  2021-03-18

5.  Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.

Authors:  Joëlla W Adams; Alexandra Savinkina; James C Hudspeth; Mam Jarra Gai; Raagini Jawa; Laura R Marks; Benjamin P Linas; Alison Hill; Jason Flood; Simeon Kimmel; Joshua A Barocas
Journal:  JAMA Netw Open       Date:  2022-02-01

6.  A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs.

Authors:  Kristina T Phillips; Catherine Stewart; Bradley J Anderson; Jane M Liebschutz; Debra S Herman; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2021-02-27       Impact factor: 4.492

7.  Injections and infections: understanding syringe service program utilization in a rural state.

Authors:  Kinna Thakarar; Nitysari Sankar; Kimberly Murray; Frances L Lucas; Debra Burris; Robert P Smith
Journal:  Harm Reduct J       Date:  2021-07-17

8.  Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review.

Authors:  Thomas D Brothers; Dan Lewer; Matthew Bonn; Duncan Webster; Magdalena Harris
Journal:  BMJ Open       Date:  2021-08-09       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.